The use of orthopaedic shoes in patients with diabetes at high risk of foot amputation and Charcot arthropathy

被引:0
|
作者
Demina, A. G. [1 ,2 ]
Bregovskiy, V. B. [1 ,2 ]
Karpova, I. A. [2 ]
机构
[1] Federal North West Med Res Ctr, St Petersburg, Russia
[2] City Diabet Ctr, St Petersburg, Russia
来源
DIABETES MELLITUS | 2015年 / 18卷 / 04期
关键词
diabetes mellitus; diabetic foot; orthopedic footwear; diabetic neuroosteoarthropathia; Charcot foot;
D O I
10.14341/DM7186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To evaluate the use of orthopaedic shoes in patients with diabetes with foot ulcers and/or previous minor amputations or Charcot arthropathy (CA) and factors influencing this use. Patients and methods. One hundred twenty-one patients with diabetes (55 men and 66 women; 36 in the inactive stage of CA) were included. A questionnaire based on footwear was used to evaluate patients' compliance. Daily activity and the severity of the foot deformities were recorded. Further, foot geometry and forefoot and midfoot circumferences were measured. Results. Fifty-eight patients did not use orthopaedic shoes. Users and non-users did not differ in terms of gender and type of diabetes. The causes of refusal included ill-fitting shoes (56%), ugly appearance (11%), traumatisation with shoes (11%), inability to walk (5%) and other causes (17%). The percentages of patients in each category of deformity severity were mild (41.2%), moderate (37%) and severe (54%. Frequency of refusal of CA vs non-CA patients: 72.2% and 43.5%; with severe deformities, 70.8% vs 34%; with moderate deformities, 83.3% vs 57.2% (p < 0.05 for all). In patients with CA, the only significant parameter was the difference in the circumference of the midfoot between the affected and non-affected foot; in CA users and non-users, this parameter was 1.93 +/- 1.25 vs 0.70 +/- 0.83 cm, respectively (p = 0.01). Conclusions. The high frequency of refusing to wear orthopaedic shoes is related to severe foot deformities and the inability to accommodate them in off-the-shelf footwear. Most of the patients used orthopaedic shoes for outdoor use, but the frequency of use was low. Shoe compliance did not depend on gender but increased with ageing, low levels of daily activity and in patients with severe deformities. Patients with CA are characterised with extremely low compliance. In this group, foot parameters and other objective parameters did not rely on footwear compliance.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [1] Painful Nonunion in Patients With Clinically Plantigrade Diabetes-Associated Charcot Foot Arthropathy
    Pinzur, Michael S.
    Cho, Elizabeth
    Schiff, Adam P.
    Hamid, Kamran
    FOOT & ANKLE INTERNATIONAL, 2024, 45 (09) : 925 - 930
  • [2] Use of Platelet-Rich Concentrate and Bone Marrow Aspirate in High-Risk Patients with Charcot Arthropathy of the Foot
    Pinzur, Michael S.
    FOOT & ANKLE INTERNATIONAL, 2009, 30 (02) : 124 - 127
  • [3] Functional Impairment of Patients Undergoing Surgical Correction for Charcot Foot Arthropathy
    Kroin, Ellen
    Schiff, Adam
    Pinzur, Michael S.
    Davis, Elissa S.
    Chaharbakhshi, Edwin
    DiSilvio, Frank A., Jr.
    FOOT & ANKLE INTERNATIONAL, 2017, 38 (07) : 705 - 709
  • [4] Amputation and mortality frequencies associated with diabetic Charcot foot arthropathy: a meta-analysis
    Yammine, Kaissar
    Boulos, Karl
    Assi, Chahine
    Hayek, Fady
    FOOT AND ANKLE SURGERY, 2022, 28 (08) : 1170 - 1176
  • [5] Outcomes Following Surgical Correction of Talocalcalcaneal Joint Dislocation in Diabetes Associated Charcot Foot Arthropathy
    Cho, Elizabeth
    Pinzur, Michael S.
    Schiff, Adam P.
    Hamid, Kamran
    FOOT & ANKLE INTERNATIONAL, 2024, 45 (09) : 972 - 978
  • [6] Prevalence and risk factors of Charcot Foot in patients with Diabetic Neuropathy
    Elsayed, Enas
    Edrees, Khalid
    Al Nahdi, Orjwan
    Al Jmai, Reham
    Rehab, Nagwa Ibrahim
    BIOSCIENCE RESEARCH, 2020, 17 (03): : 2101 - 2106
  • [7] Risk factors for development of nephropathy in patients with a diabetic Charcot foot
    Rasmus Bo Jansen
    Per E. Holstein
    Bo Jørgensen
    Klaus Kirketerp Møller
    Ole Lander Svendsen
    BMC Research Notes, 14
  • [8] Risk factors for development of nephropathy in patients with a diabetic Charcot foot
    Jansen, Rasmus Bo
    Holstein, Per E.
    Jorgensen, Bo
    Moller, Klaus Kirketerp
    Svendsen, Ole Lander
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [9] Bone Mineral Density in Type 2 Diabetes Patients with Charcot Arthropathy
    El Oraby, Hussein A.
    Abdelsalam, Mona M.
    Eid, Yara M.
    El Hilaly, Rana
    Marzouk, Heba A.
    CURRENT DIABETES REVIEWS, 2019, 15 (05) : 395 - 401
  • [10] High levels of anxiety and depression in diabetic patients with Charcot foot
    Chapman, Zahra
    Shuttleworth, Charles Matthew James
    Huber, Joerg Wolfgang
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2014, 7